{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05641896",
            "orgStudyIdInfo": {
                "id": "18FFAPI-2023P2"
            },
            "organization": {
                "fullName": "SOFIE",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers",
            "officialTitle": "A Phase 2, Multicenter, Single Arm, Open Label, Non-Randomized Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers",
            "acronym": "18F-FAPI-74 GI",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "study-of-fapi-pet-in-patients-with-gastrointestinal-cancers"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-04-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-07-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-11-29",
            "studyFirstSubmitQcDate": "2022-11-29",
            "studyFirstPostDateStruct": {
                "date": "2022-12-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-30",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-02",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "SOFIE",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Prospective, multi-center, open label, non-randomized clinical trial to assess efficacy of \\[18F\\]FAPI-74 to detect FAP expressing cells in patients diagnosed with gastrointestinal cancers, including hepatocellular carcinoma, cholangiocarcinoma, gastric, pancreatic and colorectal cancer. The \\[18F\\]FAPI-74 PET scan will be acquired in patients with proven GI cancers after initial staging using institutional standard methods. The PET scan results will be compared to FAP immunohistochemistry (as the primary objective) and histopathology (as the secondary objective) of the biopsied or resected tissues."
        },
        "conditionsModule": {
            "conditions": [
                "Gastrointestinal Cancers",
                "Cholangiocarcinoma",
                "Gastric Cancer",
                "Colorectal Cancer",
                "Pancreatic Ductal Adenocarcinoma",
                "Hepatocellular Carcinoma"
            ],
            "keywords": [
                "Fibroblast Activation Protein",
                "Fibroblast Activation Protein Inhibitor",
                "FAPI",
                "Gastrointestinal Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 120,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "[18F]FAPI-74 PET/CT",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive \\[18F\\]FAPI-74 intravenously followed by PET/CT 60 minutes (+/-10minutes) later",
                    "interventionNames": [
                        "Drug: [18F]FAPI-74 PET/CT"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "[18F]FAPI-74 PET/CT",
                    "description": "\\[18F\\]FAPI-74 is a radioactive diagnostic agent indicated for use with Positron Emission Tomography (PET) imaging for the detection of Fibroblast Activation Protein (FAP) positive cancer cells and cancer-associated fibroblasts (CAF) in patients with gastrointestinal cancers.",
                    "armGroupLabels": [
                        "[18F]FAPI-74 PET/CT"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Positive predictive value will be determined on a per-lesion basis for all lesions with tissue available for FAP analysis.",
                    "description": "Lesions positive for FAP as detected by immunohistochemistry and Lesions positive for FAP as detected by \\[18F\\]FAPI-74 PET imaging",
                    "timeFrame": "Through study completion, 2 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Positive predictive value will be determined on a per-lesion basis for all lesions with tissue available for histopathology.",
                    "description": "Malignant lesions as detected by histopathology and Lesions positive for FAP as detected by \\[18F\\]FAPI-74 PET imaging",
                    "timeFrame": "Through study completion, 2 years"
                },
                {
                    "measure": "Further characterize the safety profile of [18F]FAPI-74 in subjects utilizing Common Terminology Criteria for Adverse Events (CTCAE v5)",
                    "description": "Incidence and severity of treatment emergent adverse events occurring within 24 hours.",
                    "timeFrame": "Through study completion, 2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Confirmed diagnosis of gastrointestinal (GI) malignancy, including hepatocellular carcinoma, cholangiocarcinoma, gastric, pancreatic and colorectal cancer\n* Available tissue sample obtained through biopsy or to be obtained through scheduled biopsy and/or surgical resection\n* No treatment received between tissue sample taken and \\[18F\\]FAPI-74 PET\n* Anatomic imaging (e.g., CT, MRI) obtained within \u2264 28 days of consent\n* Age \u2265 18 years\n* Completed informed consent as determined per the IRB of record\n\nExclusion Criteria:\n\n* Pregnant as determined by a pregnancy test as per institutional guidelines for individuals of child-bearing potential\n* Declining to use effective contraceptive methods during the study (for individuals of child-producing potential)\n* Need for emergent surgery that would be delayed by participation\n* Bacterial, viral, or fungal infections requiring systemic therapy, that are expected to impact FAP expression in the opinion of the sponsor or their designee\n* Serious co-morbidities and serious nonmalignant disease (e.g., hydronephrosis, kidney failure, liver failure, systemic or local inflammatory or autoimmune diseases or other conditions) that in the opinion of the investigator, physician of record and/or Sofie could compromise subject safety and/or protocol objectives\n* Known diagnosis of an autoimmune disorder that is expected to impact FAP expression in the opinion of the sponsor or their designee\n* Patients receiving any other investigational agent within the past 28 days\n* Breastfeeding. Note: nursing parents are allowed if the potential participant commits to pumping breast milk and discarding it from injection to \u2265 24 hours from the time of the \\[18F\\]FAPI-74 injection\n* Known hypersensitivity to any excipients used in \\[18F\\]FAPI-74: trace amounts of sodium acetate, sodium ascorbate, ascorbic acid, ethanol, acetonitrile or AlCl.\n* Renal or liver function impairment\\* \\*Defined by liver impairments as AST\\>3x the upper limit of normal, ALT\\>3x the upper limit of normal, or bilirubin\\>1.5x the upper limit of normal. Renal impairment as defined by a creatinine clearance of \\>1.5x the upper limit of normal utilizing the Cockcroft Gault formula",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sherly Mosessian, Ph.D",
                    "role": "CONTACT",
                    "phone": "818-400-7620",
                    "email": "sherly.mosessian@sofie.com"
                },
                {
                    "name": "Bridget Adams",
                    "role": "CONTACT",
                    "phone": "319-430-1192",
                    "email": "bridget.adams@sofie.com"
                }
            ],
            "locations": [
                {
                    "facility": "University of California Los Angeles (UCLA) Health",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Aletta Deranteriassian",
                            "role": "CONTACT",
                            "email": "ADeranteriassian@mednet.ucla.edu"
                        },
                        {
                            "name": "Mark Girgis, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Jeremie Calais, M.D., M.Sc",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Massachusetts general hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Deanna Pucillo",
                            "role": "CONTACT",
                            "phone": "617-726-1312",
                            "email": "dmpucillo@mgh.harvard.edu"
                        },
                        {
                            "name": "Shadi Abdar Esfahani, MD, MPH",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "BAMF Health",
                    "status": "RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49503",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clayton McNamara, RN",
                            "role": "CONTACT",
                            "phone": "616-330-2735",
                            "email": "Clayton.mcnamara@bamfhealth.com"
                        },
                        {
                            "name": "Harshad Kulkarni, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "Northwell Health",
                    "status": "RECRUITING",
                    "city": "Lake Success",
                    "state": "New York",
                    "zip": "11042",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christopher Caravella, MHA",
                            "role": "CONTACT",
                            "phone": "631-449-3133",
                            "email": "ccaravella@northwell.edu"
                        },
                        {
                            "name": "Josephine N Rini, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.77066,
                        "lon": -73.71763
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center (MSKCC)",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Abby Guruparan",
                            "role": "CONTACT",
                            "email": "gurupara@mskcc.org"
                        },
                        {
                            "name": "Ali-Aria Razmaria, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000018281",
                    "term": "Cholangiocarcinoma"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M9613",
                    "name": "Carcinoma, Hepatocellular",
                    "relevance": "LOW"
                },
                {
                    "id": "M16064",
                    "name": "Stomach Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M20426",
                    "name": "Cholangiocarcinoma",
                    "asFound": "Cholangiocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "asFound": "Gastrointestinal Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "T5486",
                    "name": "Stomach Cancer",
                    "relevance": "LOW"
                },
                {
                    "id": "T755",
                    "name": "Bile Duct Cancer",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}